Cancer statistics, 2026: Charting a course for a national cancer research agenda
In the subsequent SURMOUNT-2 trial, tirzepatide was studied in patients with diabetes and 79-83% patients achieved 5% weight loss or more on the 10 or 15 mg dose.3 Comparatively, patients receiving semaglutide 2.4 mg (the highest dose studied) achieved 5% weight loss or more in 86.4% patients without diabetes4 and in only 68.8% patients with diabetes.5 It is tempting to conclude that male patients with type 2 diabetes may have a better chance of achieving weight loss goals with tirzepatide rather than semaglutide based on these data
Our team serves patients across Arlington, Richardson, Dallas, and Texarkana, TX
Tranexamic Acid helps reduce melanin synthesis by controlling pigment activation pathways, while L-Glutathione provides strong antioxidant and skin detoxification support , promoting clearer and healthier skin appearance
Loss of function of retinoblastoma (Rb) protein is an important event in the development of liver cancer